Lantern Pharma Inc. (LTRN) — Institutional Holders, Q2 2026

39 institutional investment managers reported a LTRN position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $12.0M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

LTRN in Q2 2026: what funds did

Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.

New positions

13

Added to

9

Trimmed

7

Sold out

6

Biggest buyers

  1. Empery Asset ManagementNew · +842,669 sh+$3.5M
  2. CM ManagementAdded · +250,000 sh+$1.0M
  3. RENAISSANCE TECHNOLOGIESAdded · +175,039 sh+$729.9K
  4. VANGUARD CAPITAL MANAGEMENTAdded · +93,039 sh+$388.0K
  5. CITADEL ADVISORSNew · +47,895 sh+$199.7K

Biggest sellers

  1. BIOS Capital ManagementTrimmed · -615,038 sh-$2.6M
  2. Voss CapitalSold out · -50,000 sh-$208.5K
  3. BlackRockTrimmed · -22,917 sh-$95.6K
  4. DIMENSIONAL FUND ADVISORSTrimmed · -21,335 sh-$89.0K
  5. GEODE CAPITAL MANAGEMENTTrimmed · -8,827 sh-$36.8K

LTRN 13F holders ranked 1–39 of 39

Institutional investors reporting a position in Lantern Pharma Inc. on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
Empery Asset Management#1 · 842,669 sh$3.5MNew
CM Management#2 · 500,000 sh$2.1M+100.0%
VANGUARD CAPITAL MANAGEMENT#3 · 425,118 sh$1.8M+28.0%
RENAISSANCE TECHNOLOGIES#4 · 291,039 sh$1.2M+150.9%
BIOS Capital Management#5 · 249,397 sh$1.0M-71.1%
GEODE CAPITAL MANAGEMENT#6 · 102,819 sh$428.9K-7.9%
VANGUARD FIDUCIARY#7 · 49,950 sh$208.3K+0.7%
CITADEL ADVISORS#8 · 47,895 sh$199.7KNew
Westside Investment Management#9 · 47,850 sh$199.5K-4.4%
Quadrature Capital Ltd#10 · 39,593 sh$165.1KNew
NewEdge Advisors#11 · 27,049 sh$112.8KNew
HORIZON KINETICS ASSET MANAGEMENT#12 · 25,164 sh$104.9K-4.6%
DAVENPORT#13 · 23,814 sh$99.3K0.0%
STATE STREET#14 · 23,652 sh$98.6K0.0%
BlackRock#15 · 22,350 sh$93.2K-50.6%
Bank of New York Mellon#16 · 21,301 sh$88.8K0.0%
NORTHERN#17 · 17,485 sh$72.9K+12.2%
XTX Topco Ltd#18 · 17,415 sh$72.6KNew
DIMENSIONAL FUND ADVISORS#19 · 16,725 sh$69.7K-56.1%
UBS Group AG#20 · 16,632 sh$69.4K+65.0%
Focus Partners Wealth#21 · 15,432 sh$64.4K0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP#22 · 14,073 sh$58.7KNew
Cetera Investment Advisers#23 · 12,228 sh$51.0K0.0%
MARSHALL WACE, LLP#24 · 11,946 sh$49.8KNew
Farther Finance Advisors#25 · 10,975 sh$45.8KNew
Vanguard Global Advisers#26 · 2,355 sh$9.8K0.0%
SIMPLEX TRADING#27 · 2,337 sh$9.7K+2084.1%
SBI Securities , Ltd.#28 · 2,159 sh$9.0K+0.7%
Tower Research Capital (TRC)#29 · 1,162 sh$4.8K-67.4%
MORGAN STANLEY#30 · 639 sh$2.7K+6.3%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT#31 · 500 sh$2.1K0.0%
ENTRUST FINANCIAL#32 · 500 sh$2.1KNew
OSAIC#33 · 220 sh$917.000.0%
Physician Wealth Advisors#34 · 158 sh$659.00New
Rialto Wealth Management#35 · 123 sh$513.00New
PlanVest Financial#36 · 100 sh$417.00New
GROUP ONE TRADING, L.P.#37 · 23 sh$96.000.0%
BARCLAYS PLC#38 · 6 sh$25.00New
Key FInancial#39 · 2 sh$8.000.0%

Funds that sold out of LTRN in Q2 2026 (6)

Held LTRN at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.

Institutions that held LTRN in Q1 2026 and reported no position in Q2 2026.
InstitutionValue in Q1 2026
Voss Capital50,000 sh$68.5K
CURIO WEALTH2,000 sh$2.7K
WELLS FARGO & COMPANY1,475 sh$2.0K
FMR500 sh$685.00
JPMORGAN CHASE97 sh$120.00
CITIGROUP45 sh$62.00

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.